Prevalent serotypes ofBordetella pertussisin non-vaccinated communities
- 1 August 1976
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 77 (1) , 85-91
- https://doi.org/10.1017/s0022172400055546
Abstract
SUMMARY: In many countries, the prevalent serotypes ofBordetella pertussishave changed from a mixture of types 1,2,3 and 1,2 (organisms possessing antigen 2) to a predominance of type 1,3. The timing of the change in different countries is shown to be related to the introduction of mass-vaccination with material rich in antigens 1 and 2 but weak in, or devoid of, antigen 3. In several parts of the world, there have been outbreaks of type 1,3 infection in fully vaccinated children.Non-vaccinated communities in various parts of the world still show the pattern of serotypes which existed elsewhere before mass-vaccination.In order to avoid the disappointments experienced in the past, it is essential that pertussis vaccine for use in previously non-vaccinated communities, like that for any other country, should be rich in each of the three antigens.This publication has 22 references indexed in Scilit:
- PROTECTION BY PERTUSSIS VACCINE: Little Cause for ConcernThe Lancet, 1976
- Mouse or man? Which are pertussis vaccines to protect?Epidemiology and Infection, 1976
- Variation of serotype in strains of Bordetella pertussisEpidemiology and Infection, 1974
- Pertussis agglutinins in vaccinated children: better response with adjuvantEpidemiology and Infection, 1974
- Experimental pertussis infection in the marmoset: type specificity of active immunityEpidemiology and Infection, 1974
- Vaccination against whooping-cough.BMJ, 1969
- Whooping-coughBMJ, 1965
- Effectiveness of Pertussis VaccinesBMJ, 1965
- Type-specific Immunity Against Whooping-coughBMJ, 1963
- SEROLOGICAL STUDIES ON H. PERTUSSIS, H. PARAPERTUSSIS AND H. BRONCHISEPTICUSActa Pathologica Microbiologica Scandinavica, 1953